Literature DB >> 25113765

Radical irradiation of extracranial oligometastases.

Joseph K Salama1, Michael T Milano2.   

Abstract

Advances in radiotherapy planning and delivery have been used to treat patients with limited metastatic disease. With these techniques, high rates of treated metastasis control and low toxicity have been reported. Some patients have long disease-free intervals after radiotherapy similar to those seen after surgical resection. Ongoing studies will determine the benefit of these irradiation techniques to treat limited metastases, identify appropriate candidates, and assist in integrating these treatments into management strategies for specific diseases.
© 2014 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2014        PMID: 25113765      PMCID: PMC4152719          DOI: 10.1200/JCO.2014.55.9567

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  142 in total

1.  Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis.

Authors:  Samuel Ryu; Fang Fang Yin; Jack Rock; Jingeng Zhu; Archie Chu; Eduard Kagan; Lisa Rogers; Munther Ajlouni; Mark Rosenblum; Jae Ho Kim
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

Review 2.  Review and uses of stereotactic body radiation therapy for oligometastases.

Authors:  Filippo Alongi; Stefano Arcangeli; Andrea Riccardo Filippi; Umberto Ricardi; Marta Scorsetti
Journal:  Oncologist       Date:  2012-06-20

3.  Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect.

Authors:  Dominique Elias; Gabriel Liberale; Déwi Vernerey; Marc Pocard; Michel Ducreux; Valérie Boige; David Malka; Jean-Pierre Pignon; Philippe Lasser
Journal:  Ann Surg Oncol       Date:  2005-09-26       Impact factor: 5.344

4.  Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer.

Authors:  J A Bonner; R T Eagan; V Liengswangwong; S Frytak; E G Shaw; R G Evans; E T Creagan; R L Richardson
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

Review 5.  Karnofsky Memorial Lecture. Natural history of small breast cancers.

Authors:  S Hellman
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544

6.  Liver resection for colorectal metastases.

Authors:  Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

7.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

8.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients.

Authors:  H Blomgren; I Lax; I Näslund; R Svanström
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

9.  Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis.

Authors:  Kyle E Rusthoven; Susan F Hammerman; Brian D Kavanagh; Michael J Birtwhistle; Mark Stares; D Ross Camidge
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

10.  Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991.

Authors:  M Wroński; E Arbit; M Burt; J H Galicich
Journal:  J Neurosurg       Date:  1995-10       Impact factor: 5.115

View more
  28 in total

Review 1.  Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer.

Authors:  Meghan Campo; Hani Al-Halabi; Melin Khandekar; Alice T Shaw; Lecia V Sequist; Henning Willers
Journal:  Oncologist       Date:  2016-06-27

2.  Oligometastases to the liver: predicting outcomes based upon radiation sensitivity.

Authors:  Haoming Qiu; Alan W Katz; Michael T Milano
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 3.  Emerging Treatment Paradigms in Radiation Oncology.

Authors:  Quynh-Thu Le; Hiroki Shirato; Amato J Giaccia; Albert C Koong
Journal:  Clin Cancer Res       Date:  2015-05-19       Impact factor: 12.531

4.  Radiation oncology: a snapshot in time, 2014.

Authors:  Brian D Kavanagh; Bruce G Haffty; Joel E Tepper
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

5.  Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes.

Authors:  Brian D Kavanagh
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

6.  Signals from SABR-COMET time to move on to phase III studies.

Authors:  Michael T Milano; Amit K Chowdhry; Joseph K Salama; Steven J Chmura
Journal:  Ann Transl Med       Date:  2019-12

Review 7.  Molecular radiobiology: the state of the art.

Authors:  Amato J Giaccia
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

8.  Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study.

Authors:  Ori Barzilai; Anne L Versteeg; Arjun Sahgal; Laurence D Rhines; Mark H Bilsky; Daniel M Sciubba; James M Schuster; Michael H Weber; Peter Pal Varga; Stefano Boriani; Chetan Bettegowda; Michael G Fehlings; Yoshiya Yamada; Michelle J Clarke; Paul M Arnold; Ziya L Gokaslan; Charles G Fisher; Ilya Laufer
Journal:  Cancer       Date:  2018-11-29       Impact factor: 6.860

Review 9.  Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.

Authors:  Alessandro Inno; Giuseppe Bogina; Monica Turazza; Laura Bortesi; Simona Duranti; Alberto Massocco; Giuseppe Zamboni; Giovanni Carbognin; Filippo Alongi; Matteo Salgarello; Stefania Gori
Journal:  Oncologist       Date:  2015-12-09

10.  Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases.

Authors:  A J Conde-Moreno; J L Lopez-Guerra; V A Macias; M L Vázquez de la Torre; P Samper Ots; S San José-Maderuelo; J Pastor Peidro; J López-Torrecilla; J Expósito-Hernández
Journal:  Clin Transl Oncol       Date:  2015-09-02       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.